Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations

被引:181
作者
Rigouts, Leen [1 ,2 ]
Gumusbog, Mourad [1 ]
de Rijk, Willem Bram [1 ]
Nduwamahoro, Elie [1 ]
Uwizeye, Cecile [1 ]
de Jong, Bouke [1 ]
Van Deun, Armand [1 ]
机构
[1] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium
[2] Univ Antwerp, B-2020 Antwerp, Belgium
关键词
RAPID DETECTION; ASSAY; SUSCEPTIBILITY; PERFORMANCE; COST; GENE;
D O I
10.1128/JCM.02741-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
WHO-endorsed phenotypic drug susceptibility testing (DST) methods for Mycobacterium tuberculosis are assumed to be the gold standard for identifying rifampin (RMP) resistance. However, previous results indicated that low-level, yet probably clinically relevant, RMP resistance linked to specific rpoB mutations is easily missed by some growth-based methods. We aimed to compare the level of resistance detected on Lowenstein-Jensen (LJ) medium with resistance detected by the Bactec MGIT 960 automated DST (MGIT-DST) system for various rpoB mutants. Full agreement between LJ and MGIT-DST was observed for mutations located at codons 513 (Lys or Pro) and 531 (Leu, Trp), which were always resistant by both methods. For mutations 511Pro, 516Tyr, 533Pro, 572Phe, and several 526 mutations, LJ and MGIT results were highly discordant, with MGIT-DST failing to give a result or declaring the strains susceptible. Our data show that phenotypic RMP resistance testing of M. tuberculosis is not a binary phenomenon for some rpoB mutations and that the widely used automated MGIT 960 system is prone to miss some RMP resistance-conferring mutations, while careful DST on LJ missed hardly any. Given the association of these mutations with poor clinical outcome, our findings suggest that the gold standard for rifampin resistance should be reconsidered, in order to address the present confusion caused by discrepancies between phenotypic and genotypic results. The impacts of these mutations will depend on the frequency of their occurrence, which may vary from one setting to another.
引用
收藏
页码:2641 / 2645
页数:5
相关论文
共 23 条
[1]  
Ahmad S, 2009, INDIAN J EXP BIOL, V47, P454
[2]  
Al-Mutairi NM, 2011, INT J TUBERC LUNG D, V15, P110
[3]  
[Anonymous], 2011, LANCET INFECT DIS, V11, P333
[4]   Mechanisms of isoniazid resistance in Mycobacterium tuberculosis [J].
Barry, CE ;
Slayden, RA ;
Mludli, K .
DRUG RESISTANCE UPDATES, 1998, 1 (02) :128-134
[5]   Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis [J].
Billington, OJ ;
McHugh, TD ;
Gillespie, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1866-1869
[6]   Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis [J].
Campbell, Patricia J. ;
Morlock, Glenn P. ;
Sikes, R. David ;
Dalton, Tracy L. ;
Metchock, Beverly ;
Starks, Angela M. ;
Hooks, Delaina P. ;
Cowan, Lauren S. ;
Plikaytis, Bonnie B. ;
Posey, James E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) :2032-2041
[7]  
CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565
[8]   rpoB gene mutation profile in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Guizhou, one of the highest incidence rate regions in China [J].
Chen, Ling ;
Gan, Xin ;
Li, Nana ;
Wang, Jianhua ;
Li, Kailun ;
Zhang, Hong .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) :1299-1301
[9]   The competitive cost of antibiotic resistance in Mycobacterium tuberculosis [J].
Gagneux, Sebastien ;
Long, Clara Davis ;
Small, Peter M. ;
Van, Tran ;
Schoolnik, Gary K. ;
Bohannan, Brendan J. M. .
SCIENCE, 2006, 312 (5782) :1944-1946
[10]   Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology [J].
Kamerbeek, J ;
Schouls, L ;
Kolk, A ;
vanAgterveld, M ;
vanSoolingen, D ;
Kuijper, S ;
Bunschoten, A ;
Molhuizen, H ;
Shaw, R ;
Goyal, M ;
vanEmbden, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (04) :907-914